Literature DB >> 3033240

Effect of low dose methotrexate on neutrophil chemotaxis induced by leukotriene B4 and complement C5a.

C R Suarez, W C Pickett, D H Bell, D K McClintock, A L Oronsky, S S Kerwar.   

Abstract

When mediators of inflammation such as complement component C5a or leukotriene B4 are introduced into an air pouch created in mice, these mediators induce the migration of neutrophils into the air pouch. Pretreatment of mice with low doses of methotrexate inhibits leukotriene B4 or C5a induced neutrophil migration into the air pouch. Inhibition of neutrophil chemotaxis by methotrexate may, at least in part, account for the rapid onset of antiinflammatory activity that was observed in clinical trials with methotrexate in rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3033240

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  10 in total

1.  Induction of plasma exudation and inflammatory cell infiltration by leukotriene C4 and leukotriene B4 in mouse peritonitis.

Authors:  D E Griswold; E F Webb; L M Hillegass
Journal:  Inflammation       Date:  1991-08       Impact factor: 4.092

2.  Modified skin-window technique in cynomolgus macaques (Macaca fasicularis) for assessing neutrophil extravasation.

Authors:  Sean Maguire; Eric Dobrzynski; R Katherine Alpaugh
Journal:  J Am Assoc Lab Anim Sci       Date:  2010-07       Impact factor: 1.232

3.  Characterization of the pharmacological profile of the potent LTB4 antagonist CP-105,696 on murine LTB4 receptors in vitro.

Authors:  H J Showell; R Breslow; M J Conklyn; G P Hingorani; K Koch
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

4.  Short term effect of methotrexate in severe steroid-dependent asthma.

Authors:  G Kanzow; D Nowak; H Magnussen
Journal:  Lung       Date:  1995       Impact factor: 2.584

5.  The effect of methotrexate on lipoxygenase metabolism in neutrophils from rats: in vitro and ex vivo studies.

Authors:  J S Hawkes; L G Cleland; M J James
Journal:  Agents Actions       Date:  1993-11

6.  Immune tolerance induction to enzyme-replacement therapy by co-administration of short-term, low-dose methotrexate in a murine Pompe disease model.

Authors:  A Joseph; K Munroe; M Housman; R Garman; S Richards
Journal:  Clin Exp Immunol       Date:  2008-02-25       Impact factor: 4.330

7.  Colchicine and methotrexate reduce leukocyte adherence and emigration in rat mesenteric venules.

Authors:  H Asako; P Kubes; B A Baethge; R E Wolf; D N Granger
Journal:  Inflammation       Date:  1992-02       Impact factor: 4.092

8.  Divergent effects of methotrexate on the clonal growth of T and B lymphocytes and synovial adherent cells from patients with rheumatoid arthritis.

Authors:  A Nakajima; M Hakoda; H Yamanaka; N Kamatani; S Kashiwazaki
Journal:  Ann Rheum Dis       Date:  1996-04       Impact factor: 19.103

9.  Treatment of experimental adjuvant arthritis with the combination of methotrexate and lyophilized Enterococcus faecium enriched with organic selenium.

Authors:  J Rovenský; K Svík; M Stancíková; R Istok; L Ebringer; M Ferencík
Journal:  Folia Microbiol (Praha)       Date:  2002       Impact factor: 2.099

10.  Methotrexate Alters the Expression of microRNA in Fibroblast-like Synovial Cells in Rheumatoid Arthritis.

Authors:  Naoki Iwamoto; Kaori Furukawa; Yushiro Endo; Toshimasa Shimizu; Remi Sumiyoshi; Masataka Umeda; Tomohiro Koga; Shin-Ya Kawashiri; Takashi Igawa; Kunihiro Ichinose; Mami Tamai; Tomoki Origuchi; Atsushi Kawakami
Journal:  Int J Mol Sci       Date:  2021-10-26       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.